Mani (TSE:7730) Beta: 0.7374 (As of Jun. 26, 2026)


TSE:7730 Mani Inc TSE:7730
98 GF Score
Price 円1,705.00
GF Value 円2,113.86
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Mani Beta?

Mani TSE:7730 +0.83% 98 Beta is 0.7374 as of Jun. 26, 2026. GuruFocus rates TSE:7730 with a GF Score™ of 98/100 and a GF Value™ of 円2,113.86 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2026-06-26), Mani's Beta is 0.7374.


Mani  (TSE:7730) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Mani Beta Related Terms


Mani Beta Historical Data

* Premium members only.

The historical data trend for Mani's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mani Beta Chart

Mani Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Beta
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.67 0.41 0.41 0.45 0.53

Mani Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.59 0.69 0.53 0.61 0.66

TSE:7730 vs ISRG, BDX, MDLN: Beta Comparison

For the Medical Instruments & Supplies subindustry, Mani's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mani Beta vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Mani's Beta distribution charts can be found below:

* The bar in red indicates where Mani's Beta falls into.


TSE:7730
98GF Score
Mani Inc TSE:7730
Beta is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mani Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.

Frequently Asked Questions Learn more about Beta →
What does a Beta of 0.7374 mean?
Mani (TSE:7730) has a Beta of 0.7374 as of Jun. 26, 2026. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Mani and its competitors.
Is Mani's Beta too high?
Mani's current Beta is 0.7374. Overall, Mani has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Mani's Beta compare to ISRG and BDX?
Mani's Beta of 0.7374 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beta for a Medical Devices & Instruments company?
A good Beta depends on the Medical Devices & Instruments industry context. However, Beta should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beta mean?
A high Beta can signal that a stock is expensive relative to its fundamentals. Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. View historical data for Mani and its competitors. Mani's current Beta is 0.7374. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mani stock overvalued right now?
Based on GuruFocus' analysis, Mani (TSE:7730) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,113.86, compared to a current price of 円1,705.00 — trading 19.3% below its estimated fair value. The current Beta is 0.7374. Mani's overall GF Score™ is 98/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beta calculated?
Beta is calculated from a company's financial statements. For Mani (TSE:7730), the current Beta is 0.7374 as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mani (TSE:7730) Overvalued in 2026?

Based on GuruFocus' analysis, Mani stock appears to be undervalued. The current stock price of 円1,705.00 is trading 19.3% below its estimated GF Value™ of 円2,113.86. GuruFocus considers Mani to be Modestly Undervalued.

Key valuation signals for TSE:7730:

  • Beta: 0.7374
  • GF Value™: 円2,113.86 vs. price of 円1,705.00 (19.3% below fair value)
  • GF Score™: 98/100 with 6 warning signs

No single metric tells the full story. See the TSE:7730 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Mani Business Description

Address 8-3 Kogyodanchi, Tochigi, JPN
Mani Inc manufactures medical devices and dental instruments. It sells products in four categories: surgical instruments, ophthalmic instruments, suture needles, and dental instruments. Mani's surgical products include instruments such as staplers, vessel knives, and bone saws. Its ophthalmic instruments include a range of knives used during eye surgery and ophthalmic sutures. Mani's suture needles business includes a variety of taper point and cutting eyeless needles, which require suture attachment and sterilization by the customer, as well as stainless-steel eyed needles. The firm's dental instruments include endodontic instruments and accessories, root canal equipment, and finishing and polishing instruments.
98GF Score

Get the complete analysis for TSE:7730

Beta is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,705.00
Price
円2,113.86
GF Value